Monday, December 11, 2023

Hodgkin lymphoma prognosis, biology tracked with circulating tumor DNA

Circulating tumor DNA predicts recurrence and splits disease into two subgroups of Hodgkin lymphoma. New drug targets or changes in treatments may reduce toxicity.

from Top Health News -- ScienceDaily https://ift.tt/udcbXlx
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New drugs could wipe out the “zombie cells” linked to cancer and aging

Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These sen...